- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03031899
Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy
Efficacy of Rose Bengal in Comparison With Toluidine Blue in Detection of Premalignant Lesions: a Preliminary Study
Abstract
Objective:
To study the diagnostic efficiency of Rose Bengal with Toluidine blue in detecting the biopsy sites and thus establish an accurate diagnosis in oral premalignant lesions.
Materials and method:
In our study 27 patients with 41 lesions were included. Since one patient had not quit the habit in the two weeks following initial examination and another lesion disappeared in the waiting period, 2 patients (3 lesions) were not included in the study. Out of 38 lesions diagnosed based on clinical criteria, 32 were leukoplakia, 5 lichen planus and 1 SCC. After initial examination they were subjected to Rose Bengal and Toluidine blue stain. If stained positive they were subjected to biopsy.
Study Overview
Status
Intervention / Treatment
Detailed Description
Introduction Toluidine blue staining is the most common technique used for the early detection of dysplastic changes in patients with premalignant lesions. One meta-analysis of Rosenberg et al. previously published reported sensitivity ranged from 93.5% to 97.8% and the specificity ranged from 73.3% to 92.9%. Zang et al reported that TB not only detects high-grade dysplasia but detects OPLs with minimal or no dysplasia with high-risk clinical and molecular attributes.4 But, studies have shown as high as 30% risk of false-positive staining.
Rose Bengal (RB) has been widely used to diagnose various ocular surface disorders including delineation of the extent of corneal and conjunctival neoplasms. It has been believed to stain desquamated ocular epithelial cells, dead or degenerated cells, or wherever there is poor protection of the surface epithelium by the preocular tear film rather than lack of cell vitality. These characteristic features of RB lead the researchers to apply it in oral premalignant lesions.5 In none of the studies, reliability of RB stains was not compared with existing or previously practiced methods in oral premalignant lesions. Hence this study was undertaken with the aim of comparing the RB and TB stain and for early detection of dysplasia in oral premalignant lesions.
Materials and Methods:
Study group consists of 41 oral premalignant lesions in patients visiting the Department of Oral Medicine and Radiology of The oxford dental college and hospital, Bangalore. Patients with OSMF, patients with bleeding disorders, patient with other systemic diseases were excluded from the study.To perform the present study, ethical clearance was obtained from the Institutional Ethical Board. Study procedure was explained and informed consent was taken from the selected patients with premalignant lesions. The patients with lesions were subjected to detailed case history, intra oral examination and photographs of the lesions were recorded. Patients with habits were counselled to quit the habit and recalled after 2 weeks for staining. Since one patient had not quit the habit in the two weeks from first visit, in another patient the lesion disappeared in two weeks 2 patients (3 lesions) were not included in the study. (Graph1)
Initially patients were asked to rinse their mouth with distilled water for 1 minute. 1% RB solution was applied with a cotton tip for 2 minutes. Again patients were asked to rinse their mouth for 1 minute with distilled water to remove excess RB solution and the area which had taken up the stain was photographed. Following this, patients were asked to rinse their mouth with 1% acetic acid for 1 min to remove the remaining RB stain from the lesion and were prepared for TB staining. 1%Toluidineblue is applied over the lesion and after 30 seconds patients were made to swish with 1% acetic acid and the area stained was recorded photographically.
These two photographs were assessed and if the stained area was similar in both the procedures single biopsy was taken. If the stained areas were different two different biopsies were taken.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with clinically diagnosed oral premalignant lesions (oral leukoplakia and oral lichen planus).
Exclusion Criteria:
- Patients with OSMF
- bleeding disorders and
- other systemic diseases
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Rose Bengal positive lesion and biopsy
Lesions that were stained positive with rose bengal were biopsied and assessed for dysplasia
|
rose bengal stain and toluidine is applied over a premalignant lesion and positively stained lesions are subjected to biopsy.
the lesions stained positive were subjected to biopsy
|
Toluidine blue positive lesion and biopsy
Lesions that were stained positive with toluidine blue were biopsied and assessed for dysplasia
|
rose bengal stain and toluidine is applied over a premalignant lesion and positively stained lesions are subjected to biopsy.
the lesions stained positive were subjected to biopsy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number and Percentage of Lesions That Were Stained Positive
Time Frame: 2 weeks
|
outcome measure1
|
2 weeks
|
Sensitivity and Specificity (Percentage of True Positives and True Negatives)
Time Frame: 2 weeks
|
sensitivity: Percentage of lesions stained positive with Toluidine blue stain that were also stained positive with Rose Bengal stain specificity: Percentage of lesions stained negative with Toluidine blue stain that were also stained negative with Rose Bengal stain
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal
Time Frame: 2 weeks
|
this outcome measure was limited to the biopsied lesions.additionally, the intent of this outcome measure was only to study early detection of dysplasia in oral premalignant lesions using the Rose bengal stain.
(no comparison between the two stains were intended )
|
2 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Skin Diseases
- Neoplasms
- Neoplasms by Site
- Head and Neck Neoplasms
- Stomatognathic Diseases
- Mouth Diseases
- Pathological Conditions, Anatomical
- Skin Diseases, Papulosquamous
- Mouth Neoplasms
- Lichenoid Eruptions
- Precancerous Conditions
- Leukoplakia
- Leukoplakia, Oral
- Lichen Planus, Oral
- Lichen Planus
- Molecular Mechanisms of Pharmacological Action
- Hemostatics
- Coagulants
- Heparin Antagonists
- Tolonium Chloride
Other Study ID Numbers
- 219/2014-15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Leukoplakia
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCRecruitingLeukoplakia | Erythroleukoplakia | Verrucous Oral LeukoplakiaUnited States
-
University of Erlangen-Nürnberg Medical SchoolRecruitingOral Leukoplakia | Oral Lichen Planus | Oral Leukoplakia of Tongue | Oral Leukoplakia of GingivaGermany
-
King Khalid UniversityNot yet recruiting
-
University of MinnesotaNot yet recruitingOral LeukoplakiaUnited States
-
University of California, San FranciscoWithdrawnOral LeukoplakiaUnited States
-
National Taiwan University HospitalCompleted
-
Cairo UniversityCompletedOral Cancer | Oral Leukoplakia | Oral Lichen PlanusEgypt
-
National Taiwan University HospitalNational Health Research Institutes, TaiwanUnknown
-
National Cancer Institute (NCI)TerminatedOral LeukoplakiaUnited States
-
National Cancer Institute (NCI)Completed
Clinical Trials on Biopsy
-
UNICANCERNational Cancer Institute, FranceActive, not recruitingTriple-Negative Breast NeoplasmFrance
-
Postgraduate Institute of Medical Education and...CompletedLung Cancer | Endobronchial GrowthIndia
-
Chandan SenTerminatedWound Leg | Non-Diabetic Patients | Chronic Ulcer Leg/FootUnited States
-
Duke UniversityCompletedInterstitial Lung DiseaseUnited States
-
Centre Hospitalier Universitaire de NiceUnknownParodontitis Aggressive | Parodontitis ChronicFrance
-
Ardeshir RastinehadPhilips HealthcareRecruitingProstate Cancer | Prostate Disease | Elevated Prostate Specific Antigen | Family History of Prostate Cancer | Positive Digital Rectal ExamUnited States
-
Shandong Cancer Hospital and InstituteUnknownBreast Cancer | Sentinel Lymph NodeChina
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer
-
Johns Hopkins UniversityCompleted
-
Odense University HospitalNot yet recruitingProstate Cancer (Diagnosis)